Search - tctmd.com

Displaying 21 - 40 of 77

Sort: Relevancy | Date

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Conference News ESOC 2023

TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes

Todd Neale

May 31, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

CASSISS: No Benefit of Stenting for Intracranial Stenosis

Todd Neale

August 12, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Daily News

In-Hospital Stroke Requires a Rethink: AHA

Michael O'Riordan

February 09, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

Before Age 35, Women More Vulnerable to Ischemic Stroke Than Men

Caitlin E. Cox

January 26, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

Advertisement

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

The Biggest News of 2022: TCTMD’s Top 10

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

TCTMD’s Top 10 Most Popular Stories for August 2022

What’s Going to Be Hot at ESC 2022?

CASSISS: No Benefit of Stenting for Intracranial Stenosis

More Support for Single Antiplatelet Therapy After TAVI

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

In-Hospital Stroke Requires a Rethink: AHA

February 2022 News Roundup

Before Age 35, Women More Vulnerable to Ischemic Stroke Than Men

TCTMD’s Top 10 Most Popular Stories for September 2021

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

March 2021 News Roundup

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content